Covestor’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88K Buy
396
+20
+5% +$5.53K 0.05% 432
2026
Q1
$111K Sell
376
-246
-40% -$73.1K 0.08% 250
2025
Q4
$170K Buy
622
+219
+54% +$59.5K 0.09% 283
2025
Q3
$109K Buy
403
+60
+17% +$16.3K 0.06% 530
2025
Q2
$95K Sell
343
-64
-16% -$17.4K 0.06% 581
2025
Q1
$108K Sell
407
-257
-39% -$63.4K 0.07% 435
2024
Q4
$154K Sell
664
-183
-22% -$42.1K 0.1% 283
2024
Q3
$187K Sell
847
-14
-2% -$2.9K 0.12% 204
2024
Q2
$169K Sell
861
-160
-16% -$33.1K 0.11% 211
2024
Q1
$220K Buy
1,021
+214
+27% +$45K 0.14% 134
2023
Q4
$170K Buy
807
+264
+49% +$56.3K 0.12% 208
2023
Q3
$109K Buy
543
+77
+17% +$15.3K 0.08% 362
2023
Q2
$86K Sell
466
-95
-17% -$17.6K 0.07% 526
2023
Q1
$108K Buy
561
+37
+7% +$6.69K 0.09% 335
2022
Q4
$88K Buy
524
+73
+16% +$12.7K 0.07% 454
2022
Q3
$80K Buy
451
+283
+168% +$55.9K 0.07% 470
2022
Q2
$35K Sell
168
-1
-0.6% -$212 0.03% 837
2022
Q1
$40K Buy
169
+67
+66% +$15.7K 0.03% 866
2021
Q4
$23K Buy
+102
New +$22.4K 0.03% 821

Other funds holding CME

Covestor's CME Position: Q2 2026 in Review

Covestor increased its CME Group (CME) stake by 5.3% in Q2 2026, buying an estimated $5.53K and bringing the position to 396 shares worth $88K. The position accounts for 0.05% of the portfolio, ranked #432.

Covestor first reported a position in CME in Q4 2021 and has held it in 19 quarters since. The position peaked at $220K in Q1 2024. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Covestor held 396 shares of CME Group worth $88K as of Q2 2026.
  • Covestor bought 20 CME Group shares in Q2 2026, an estimated $5.53K.
  • CME Group made up 0.05% of Covestor's portfolio in Q2 2026, its #432 holding.
  • Covestor first reported a position in CME Group in Q4 2021 and has held it in 19 quarters since.
  • Covestor's CME Group position peaked at $220K in Q1 2024.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.